MD Anderson Studies Point to Blood Tests, Vaccines and Pre-Surgery Immunotherapy at ESMO 2026
New findings presented at the ESMO Congress 2026 cover ctDNA monitoring in lung and breast cancer, a re-vaccination strategy for ...
New findings presented at the ESMO Congress 2026 cover ctDNA monitoring in lung and breast cancer, a re-vaccination strategy for ...
A narrative review argues that safety data from six phase 3 immunotherapy trials in resectable lung cancer may not transfer ...
A 2026 mini review finds that CT is established for anatomical assessment and surgical planning after neoadjuvant immunotherapy in resectable ...
Long-term results from the phase 2 NICHE-2 trial show that none of 111 patients with dMMR colon cancer treated with ...
A single-case report describes improved fitness for surgery, a reported ypT0N0 pathological response with a stated pathology-verification caveat, and no ...
Researchers developed a whole-lung radiomics AI model that predicts which lung cancer patients will achieve complete pathological response to neoadjuvant ...
A new review in Molecular Biology Reports maps how checkpoint inhibitors, engineered cell therapies, and emerging immunotherapies are transforming treatment ...
In a groundbreaking study that could reshape the landscape of treatment for non-metastatic rectal cancer, recent findings emphasize the efficacy ...
In recent years, the landscape of cancer treatment has undergone a revolutionary transformation with the introduction and advancement of immunotherapy. ...
In recent years, immune checkpoint blockade (ICB) has revolutionized the treatment landscape for various malignancies, marking a new era in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.